Quest Diagnostics
DGX
#1090
Rank
โ‚น1.457 T
Marketcap
โ‚น13,056
Share price
1.04%
Change (1 day)
15.45%
Change (1 year)
Quest Diagnostics is an American clinical laboratory company offering access to diagnostic testing services for cancer, cardiovascular disease, infectious disease, neurological disorders and employment and court ordered drug testing.

EPS for Quest Diagnostics (DGX)

EPS in 2023 (TTM): โ‚น557.67

According to Quest Diagnostics 's latest financial reports the company's current EPS (TTM) is โ‚น576.49. In 2022 the company made an earnings per share (EPS) of โ‚น687.35 a decrease over its 2021 EPS that were of โ‚น1,353.

EPS history for Quest Diagnostics from 1997 to 2023

Annual EPS

Year EPS Change
2023 (TTM)โ‚น557.67-18.87%
2022โ‚น687.35-49.21%
2021โ‚น1,35349.72%
2020โ‚น903.9666.67%
2019โ‚น542.3818%
2018โ‚น459.66-4.26%
2017โ‚น480.1223.19%
2016โ‚น389.73-7.11%
2015โ‚น419.5728.46%
2014โ‚น326.62-31.61%
2013โ‚น477.5660.46%
2012โ‚น297.63-16.51%
2011โ‚น356.472.45%
2010โ‚น347.944.35%
2009โ‚น333.4430.77%
2008โ‚น254.9968.93%
2007โ‚น150.94-40.6%
2006โ‚น254.139.96%
2005โ‚น231.1110.39%
2004โ‚น209.3616.35%
2003โ‚น179.9426.73%
2002โ‚น141.9990.29%
2001โ‚น74.6253.51%
2000โ‚น48.61-22900%
1999-โ‚น0.21-101.11%
1998โ‚น19.19-216.88%
1997-โ‚น16.42

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
โ‚น641.30 11.24%๐Ÿ‡บ๐Ÿ‡ธ USA
-โ‚น29.09-105.05%๐Ÿ‡บ๐Ÿ‡ธ USA
-โ‚น78.46-113.61%๐Ÿ‡บ๐Ÿ‡ธ USA
-โ‚น80.16-113.91%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚น124.01-78.49%๐Ÿ‡ณ๐Ÿ‡ฑ Netherlands